Study Stopped
Principal Investigator change in institution
Tracheostomy With Bedside Simultaneous Gastrostomy Vs Usual Care Tracheostomy And Delayed Gastrostomy Placement
BEGASTON
Bedside Gastrostomy With Simultaneous Tracheostomy Effect On Outcomes Of Neurocritically-Ill Patients (Proof Of Concept Study)
1 other identifier
interventional
N/A
1 country
1
Brief Summary
There is currently no prospective study analyzing the effect of tracheostomy with bedside simultaneous gastrostomy versus tracheostomy with delayed gastrostomy placement (TSG versus TDG) on the outcomes of neurocritically-ill patients. The investigators will study TSG via concomitant PDT and PUG procedures, while TDG will occur per usual care. This study is a prospective randomized open-label blinded endpoint study to assess the effect of tracheostomy with bedside simultaneous gastrostomy (TSG) versus the usual care of tracheostomy with delayed gastrostomy (TDG) placement on outcomes of neurocritically-ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedStudy Start
First participant enrolled
March 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedJune 9, 2021
June 1, 2021
9 months
February 4, 2021
June 5, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
ICU length of stay
total number of midnights a patient is in the ICU for the duration of their hospital stay
during hospital stay, assessed up to 10 days
Secondary Outcomes (10)
hospital length of stay
during hospital stay, assessed up to 10 days
nutritional metrics
up to 14 days before the procedure and up to 14-days before discharge
procedural analgo-sedation used
intraprocedure
all-cause mortality
during hospital stay, assessed up to 10 days
swallow function return
during hospital stay, assessed up to 10 days
- +5 more secondary outcomes
Study Arms (2)
simultaneous tracheostomy with gastrostomy (TSG)
EXPERIMENTALThis arm include the patients assigned to placement of gastrostomy immediately after tracheostomy.
non-simultaneous or delayed approach tracheostomy and gastrostomy (TDG)
NO INTERVENTIONThis arm include the patients who proceed with "usual care" placement of tracheostomy and gastrostomy as per Neurocritical care Unit service standard.
Interventions
Simultaneous placement of tracheostomy and gastrostomy
Eligibility Criteria
You may qualify if:
- years old- 85 years old
- Admitted under the NSICU service
- Shared-decision making with surrogate decision maker and primary neuro-intensivist agreement to proceed with tracheostomy and gastrostomy with documented discussion.
- have indications for tracheostomy and gastrostomy
- Subjects or their SDM or legally authorized representative (LARs) must voluntarily provide informed consent prior to the initiation of any study-specific procedure in a form approved by an independent IRB. In the absence of subject's ability to provide informed consent, informed consent must be given by a person who has the legal right to act on behalf of the subject in accordance with local laws.
You may not qualify if:
- Patients who require tracheostomy only or gastrostomy only
- history of prior gastrostomy, tracheostomy, laryngectomy, gastrostomy prior to tracheostomy decision, known head and neck and gastrointestinal abnormality (cancer, congenital abnormality, anatomic variants)
- withdrawal of care, a transfer from another service or hospital if patient has been there for \>24hr.
- known social discharge issues anticipating hospital stay \>100 days
- Patients with nonsurvivable injuries, anticipated mortality \<72 hours
- standard of care contraindications for either bedside tracheostomy and gastrostomy
- Absolute contraindications for gastrostomy: gastric outlet obstruction, significant gastroparesis, significant gastroesophageal reflux, a proximal high-output entercutaneous fistula
- Standard Contraindications for percutaneous gastrostomy technique: ascites, morbid obesity and esophageal and gastric pathology
- Standard Contraindications for either PEG or PUG procedures
- Standard Contraindications to percutaneous dilational tracheostomy: Gross anatomical distortion of the neck, previous neck surgery , burns, radiotherapy, unstable or rigid cervical spine, tracheal distortion, stenosis, or malacia, morbid obesity (BMI \>35kg/m2), massive thyroid gland or vessels in the operation field on ultrasound, hemodynamic instability, refractory intracranial hypertension, hemodynamic instability, Coagulopathy (Aptt\>50s, INR\>1.5, platelet count \<50,000μL, emergency need for a tracheostomy or need for a permanent tracheostoma, very difficult airway management
- Pregnancy
- Life expectancy less than three-weeks
- Goals of care disagreement between care team and LAR
- braindead
- LAR preferred procedures placed in LTAC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Christa O'Hana S. Nobleza
Jackson, Mississippi, 39216, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- blinded endpoint
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2021
First Posted
February 17, 2021
Study Start
March 31, 2021
Primary Completion
January 1, 2022
Study Completion
August 1, 2022
Last Updated
June 9, 2021
Record last verified: 2021-06